Helena Bradbury: First Haematology EAHAD Supplement of 2026
Helena Bradbury, Editorial Lead of EMJ, shared a post on LinkedIn:
“EAHAD Supplement Out Now!
I’m pleased to share our first haematology supplement of 2026, covering the 2026 Congress of the European Association for Haemophilia and Allied Disorders (EAHAD).
This issue features an exclusive interview with Congress President Ana Boban, a peer-reviewed infographic on the history of the diagnosis and management of von Willebrand disease, and a write-up of the prestigious Arosenius Lecture on the same topic.
Special thanks to Angelos Athanasopoulos and Giuliana Giardina, as well as the European Association for Haemophilia and Allied Disorders (EAHAD), for their continued partnership for a second consecutive year.
Also thanks to the EMJ team: Stacey White, Owen Silcox, Fraser Hoey, and Nabihah D.”
Stay updated with Hemostasis Today.
-
Nov 4, 2026, 18:57Connecting Haemophilia Centres, Certifying Treaters, and Improving National Data in Romania – EHC
-
Nov 4, 2026, 18:45Smitirupa Mishra: A Practical Guide to Coagulation Pathway Assessment and Laboratory Interpretation
-
Nov 4, 2026, 15:59Alessandra Bosch: A Successful Patient Day for the Bleeding Disorders Community in Zürich
-
Nov 4, 2026, 15:47Wolfgang Miesbach: Targeting Hepatic Endothelial Cells for Lentiviral Gene Therapy in Haemophilia A
-
Nov 4, 2026, 15:20Augustina Isioma Ikusemoro: Before You Transfuse, Think PBM
-
Nov 4, 2026, 14:23Advancing Hemophilia Care Through Global Research – WFH
-
Nov 4, 2026, 14:12Jean-Jacques Kiladjian: From JAK Inhibitor-Associated Skin Cancers to Laboratory Discovery
-
Nov 4, 2026, 13:59Rita Li: ASH 2026 Abstract Achievement Award for Gut Microbiome Research
-
Nov 4, 2026, 13:38Omid Seidizadeh: Improving Access to von Willebrand Disease Diagnosis and Treatment Across Europe